Lilly CEO calls out PBS pricing on Aussie TV
On the 7.30 Report last night Dave Ricks made it clear he was not interested in accepting a low-ball price to have the company's blockbuster drug listed on the PBS
On the 7.30 Report last night Dave Ricks made it clear he was not interested in accepting a low-ball price to have the company's blockbuster drug listed on the PBS
On a sabbatical year, this well-known industry executive has entered the Australian Portrait Artist of the Year Competition, painting Dannii Minogue
A survey including Aussie clinicians reveals that where treatments look clinically similar, the emotional connection a brand builds is often what separates it from the rest
A rapid review will be held into MS drugs to see whether PBAC processes compare them appropriately when recommending cost-minimised listings
With 10 prescription medicine applications on the TGA's review list, this pharma is at the forefront of bringing new therapies to Australia
Who's nabbed the former Health Minister as a Non-Executive Director to advise on medicines policy and support the company's next phase of growth?
This company has been ordered to face trial over allegations it defrauded investors by withholding information about a clinical trial for a next-gen drug
With this company ready to accelerate growth, a successful entrepreneur known across industry takes on Chair role after an oversubscribed seed funding round
The Aussie giant said it stands behind the science of the new technology but changes to the regulatory regime in the US has made the broader market less attractive
Strong growth for some drugs, sharp falls and lost exclusivity for others means the Top 10 PBS Earners list now looks very different than it did a year ago
This Aussie team is on a mid-year break to reset and recharge with a company-wide shutdown guaranteeing there will be no work interruptions and no overflowing inbox next Monday
New report lifts the lid on what rival sales reps are telling HCPs to differentiate their competing blockbuster products
An expanded PBS listing has been leapt upon by HCPs and patients, seeing reimbursements skyrocket
Aussie leader unveils his next career move after departing a top US-based role at J&J a fortnight ago
New Aussie biotech Managing Director and CEO named as predecessor readies to pursue a new opportunity overseas